APWM
GILD icon

Argonautica Private Wealth Management’s Gilead Sciences GILD Stock Holding History

Argonautica Private Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Buy
3,496
+125
+4% +$16.5K 0.11% 135
2026
Q1 		$470K Buy
3,371
+143
+4% +$20K 0.14% 134
2025
Q4 		$396K Sell
3,228
-197
-6% -$23.9K 0.12% 144
2025
Q3 		$380K Hold
3,425
– – 0.11% 146
2025
Q2 		$380K Sell
3,425
-431
-11% -$45.9K 0.12% 144
2025
Q1 		$432K Sell
3,856
-253
-6% -$26.1K 0.15% 126
2024
Q4 		$380K Sell
4,109
-67
-2% -$6.03K 0.12% 137
2024
Q3 		$350K Buy
4,176
+8
+0.2% +$610 0.12% 148
2024
Q2 		$286K Sell
4,168
-35,304
-89% -$2.36M 0.1% 164
2024
Q1 		$2.89M Buy
39,472
+1,398
+4% +$108K 1.04% 25
2023
Q4 		$3.08M Sell
38,074
-165
-0.4% -$12.8K 1.26% 21
2023
Q3 		$2.87M Buy
38,239
+120
+0.3% +$9.23K 1.29% 20
2023
Q2 		$2.94M Buy
38,119
+634
+2% +$50.6K 1.32% 20
2023
Q1 		$3.11M Sell
37,485
-2,429
-6% -$201K 1.57% 15
2022
Q4 		$3.43M Buy
+39,914
New +$3.16M 1.76% 13

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Argonautica Private Wealth Management's GILD Position: Q2 2026 in Review

Argonautica Private Wealth Management increased its Gilead Sciences (GILD) stake by 3.7% in Q2 2026, buying an estimated $16.5K and bringing the position to 3,496 shares worth $442K. The position accounts for 0.11% of the portfolio, ranked #135.

Argonautica Private Wealth Management first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.43M in Q4 2022. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Argonautica Private Wealth Management held 3,496 shares of Gilead Sciences worth $442K as of Q2 2026.
  • Argonautica Private Wealth Management bought 125 Gilead Sciences shares in Q2 2026, an estimated $16.5K.
  • Gilead Sciences made up 0.11% of Argonautica Private Wealth Management's portfolio in Q2 2026, its #135 holding.
  • Argonautica Private Wealth Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Argonautica Private Wealth Management's Gilead Sciences position peaked at $3.43M in Q4 2022.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.